Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Cai

Showing results (271-280 of 284) with videos related to

Pageof 29
Sort By:
Molecular Therapy. Nucleic Acids|January 28, 2015
Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and RabbitZhu Chen, Bin Luo, Tian-Quan Cai, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Hepatology (Baltimore, Md.)|February 15, 2013
Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort studyLi-Na Zhang, Tian-Yan Shi, Xu-Hua Shi, et al.
Journal of Medicinal Chemistry|November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptorHong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2012
Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidaseDinesh A Barawkar, Anish Bandyopadhyay, Anil Deshpande, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
American Journal of Epidemiology|February 14, 2012
Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk ChineseQuan-Cai Cai, En-Da Yu, Yi Xiao, et al.
Scientific Reports|January 23, 2021
Discovery of a new class of integrin antibodies for fibrosisJi Zhang, Tao Wang, Ashmita Saigal, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Discovery of a potent and selective small molecule hGPR91 antagonistDebnath Bhuniya, Dhananjay Umrani, Bhavesh Dave, et al.
Pageof 29

Showing results (271-280 of 284) with videos related to

Sort By:
Pageof 29
Molecular Therapy. Nucleic Acids|January 28, 2015
Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and RabbitZhu Chen, Bin Luo, Tian-Quan Cai, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Hepatology (Baltimore, Md.)|February 15, 2013
Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort studyLi-Na Zhang, Tian-Yan Shi, Xu-Hua Shi, et al.
Journal of Medicinal Chemistry|November 13, 2007
Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptorHong C Shen, Fa-Xiang Ding, Silvi Luell, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2012
Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidaseDinesh A Barawkar, Anish Bandyopadhyay, Anil Deshpande, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
American Journal of Epidemiology|February 14, 2012
Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk ChineseQuan-Cai Cai, En-Da Yu, Yi Xiao, et al.
Scientific Reports|January 23, 2021
Discovery of a new class of integrin antibodies for fibrosisJi Zhang, Tao Wang, Ashmita Saigal, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Discovery of a potent and selective small molecule hGPR91 antagonistDebnath Bhuniya, Dhananjay Umrani, Bhavesh Dave, et al.
Pageof 29